Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel Pin1 inhibitors designed and tested by German researchers

Dec. 15, 2003

Roche researchers prepare and test new dimeric antitumor agents

Dec. 15, 2003

Nonhypercalcemic vitamin D3 analogue HY-11 shows promising antileukemic activity

Dec. 12, 2003

Antiangiogenic PKC-beta inhibitor identified at J&J

Dec. 12, 2003

Genta completes NDA submission for Genasense for malignant melanoma

Dec. 12, 2003

New preclinical and phase I data presented for CYC-202

Dec. 12, 2003

Grant supports matriptase inhibitor development at Curacyte

Dec. 12, 2003

Schering AG researchers claim new PLK inhibitors for cancer and other uses

Dec. 12, 2003

Palifermin improves quality of life in cancer patients with oral mucositis

Dec. 12, 2003

New PARP inhibitors described by KuDOS and Maybridge scientists

Dec. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...